RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

Add to Collection
RCTs J Proietto, A Rissanen, JB Harp, N Erondu… - International journal of …, 2010 - nature.com

Chapter : Section1
Journal Year : 2010
Cited by : 77.0

… Incidences of adverse experiences classified in the … >160/>100 mm Hg), diabetes mellitus; and any other clinically significant … No serious laboratory adverse events were reported in this …..... Read More

Keywords : ["overweight patient lowdose study", "inverse agonist taranabant", "clinical trial assess", "safety", "obese", "efficacy"]
PubMed Link : https://www.nature.com/articles/ijo201038
Google Scholar Link : https://scholar.google.com/scholar?cites=5996510351943585735&as_sdt=5,33&sciodt=0,33&hl=en&num=20